- Report
- September 2021
- 40 Pages
China
From €2510EUR$2,600USD£2,153GBP
- Report
- January 2019
- 212 Pages
Global
From €21234EUR$22,000USD£18,215GBP
- Report
- May 2020
- 173 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- May 2020
- 79 Pages
Middle East, Africa
From €1448EUR$1,500USD£1,242GBP
- Report
- May 2020
- 79 Pages
Europe
From €1448EUR$1,500USD£1,242GBP
- Report
- May 2020
- 79 Pages
Asia Pacific
From €1448EUR$1,500USD£1,242GBP
- Report
- May 2020
- 73 Pages
North America
From €1448EUR$1,500USD£1,242GBP
- Drug Pipelines
- August 2020
- 65 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- August 2020
- 68 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- February 2020
- 40 Pages
Saudi Arabia
From €2505EUR$2,595USD£2,149GBP
- Report
- February 2020
- 40 Pages
India
From €2505EUR$2,595USD£2,149GBP
- Report
- November 2023
- 93 Pages
China
From €1737EUR$1,800USD£1,490GBP
- Report
- November 2023
- 67 Pages
China
From €1737EUR$1,800USD£1,490GBP
- Report
- September 2019
- 70 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- May 2023
- 103 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Drug Pipelines
- June 2021
- 66 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- June 2021
- 90 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Report
- February 2020
- 40 Pages
United States
From €2505EUR$2,595USD£2,149GBP
- Report
- February 2020
- 40 Pages
Russia
From €2505EUR$2,595USD£2,149GBP
- Report
- February 2020
- 40 Pages
Japan
From €2505EUR$2,595USD£2,149GBP
Bisphosphonates are a class of drugs used to treat musculoskeletal disorders, such as osteoporosis, Paget's disease, and bone metastases. They work by inhibiting the activity of osteoclasts, the cells responsible for breaking down bone. Bisphosphonates are typically administered orally or intravenously, and are available in both generic and branded forms.
Bisphosphonates are widely used in the treatment of musculoskeletal disorders, and are often prescribed in combination with other drugs. They are generally well-tolerated, with few side effects. However, long-term use of bisphosphonates has been associated with an increased risk of atypical femur fractures.
The bisphosphonates market is highly competitive, with a number of major players. These include Merck & Co., Novartis, Amgen, Sanofi, and Pfizer. Other companies in the market include Eli Lilly, GlaxoSmithKline, and Teva Pharmaceuticals. Show Less Read more